Roderick O'Connor

13PUBLICATIONS

101CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsHaematological tumoursPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 22, 2026

Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains.

|Apr 16, 2026

Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence.

|Nov 13, 2024

TET2 regulates early and late transitions in exhausted CD8<sup>+</sup> T cell differentiation and limits CAR T cell function.

Alexander J Dimitri, Amy E Baxter, Gregory M Chen

|May 20, 2024

The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour Durability.

Bakir Valentić, Andre Kelly, Alexander A Shestov

|Dec 19, 2023

Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines.

Guido Ghilardi, Luca Paruzzo, Jakub Svoboda

|Dec 06, 2023

Checkmate: Metabolic flexibility with a STING in its tail.

Roddy S O'Connor

Pageof 3

Frequent Collaborators

Bakir Valentić

Carl H June

Gabriela Plesa

Chloe Leff

Nathaniel W Snyder

Saar Gill

Marco Ruella

Amy E Baxter

Volker Wiebking

Robert Bartoszek

Frequent Collaborators

Bakir Valentić

Carl H June

Gabriela Plesa

Chloe Leff